Categorynews

Kaletra – API Insight, 2019 – ResearchAndMarkets.com

May 30, 2019 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Kaletra
– API Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s
offering.

Kaletra – API Insight, 2019
provides product and API manufacturers’ details across the globe along
with the location. The report gives the clear idea on the country wise
DMF filed by worldwide companies related to Kaletra. The report also
highlights the patent details of Kaletra.

Scope of
the Report

  • A comprehensive product overview including product description,
    regulatory milestones, safety, pharmacological properties, clinical
    trials, and product development activities have been elaborated in
    this report
  • Patent information around Kaletra in United States (US) and Europe
    (EU) has been highlighted
  • API manufacturers for Kaletra in United States, Europe, China and India
  • The report contains historical and forecasted sales for Kaletra till
    2021
  • Enlists the market competition and emerging therapies in the space
    where Kaletra operates

Reasons to Buy

  • Evaluate the marketing status of Kaletra to exploit opportunities for
    generic Kaletra development opportunities
  • Design effective counter-strategies to gain competitive advantage by
    identifying the key patent expiry details with respect to Kaletra
  • API intelligence over Kaletra and gaining primary intelligence over
    Active Ingredient manufacturers by country
  • Make more informed business decisions from insightful and in-depth
    analysis of the Kaletra ‘s performance

Key Topics Covered

1. Kaletra
Overview

2. Kaletra Global Sales Assessment

  • Kaletra Historical Global Sales
  • Kaletra Forecasted Global Sales

3. Product Description

  • Mechanism of Action
  • Pharmacodynamic Properties
  • Pharmacokinetic Properties

4. Product Details by country

5.
Patent Information

6. Global API
Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/6rkqmb

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infectious
Diseases Drugs, HIV/AIDS
Drugs